1062643

Abraxis Bioscience, LLC — FEI 3006441852

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 17, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Phoenix, AZ (United States)

Citations

IDCFRDescription
117721 CFR 211.63Equipment Design, Size and Location
180921 CFR 211.160(a)Following/documenting laboratory controls